Penn Medicine Researchers Receive 7.5 Million Dollars to Expand HIV Gene Therapy Work

Researchers from the Perelman School of Medicine and the Penn Center for AIDS Research (CFAR) have been awarded 7.5 million dollars over five years from the National Institutes of Health to initiate a multi-project HIV study investigating a new gene therapy approach to render immune cells of HIV positive patients resistant to the virus.